High Risk and Selected Benign Breast Lesions on Core Biopsy: Excision Vs Surveillance? episode artwork

EPISODE · Sep 1, 2022 · 22 MIN

High Risk and Selected Benign Breast Lesions on Core Biopsy: Excision Vs Surveillance?

from Springer Nature · host Springer Nature

The vast majority of image-detected breast abnormalities are currently diagnosed by percutaneous core needle biopsy (CNB). While management of frankly malignant lesions diagnosed by CNB is now well-defined, there is less consensus on the optimal management of high-risk and selected benign lesions diagnosed by CNB. In this episode, Dr. Benjamin Calhoun from University of North Carolina in Chapel Hill eloquently discusses the evidence for and against immediate excision of such lesions.

Episode metadata supplied by the publisher feed · Published Sep 1, 2022

Embed this episode

NOW PLAYING

High Risk and Selected Benign Breast Lesions on Core Biopsy: Excision Vs Surveillance?

0:00 22:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 22 minutes long.

When was this Springer Nature episode published?

This episode was published on September 1, 2022.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!